5- [4- (4- (2- (Amino-2-methoxycarbonylethyl) phenoxy) benzylidene] thiazolidine-2,4-dione derivatives and related compounds for reducing plasma glucose, cholesterol and triglyceride levels
Novel diphenyl ether derivatives are provided that exhibit activity useful for reducing glucose, cholesterol, and/or triglyceride levels in plasma, and for treatment of obesity, inflammation, immunological diseases, autoimmune diseases, diabetes and disorders associated with insulin resistance.